Distal hereditary motor neuropathy, Jerash type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:139552OMIM:605726G12.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Distal hereditary motor neuropathy, Jerash type (also known as dHMN Jerash type or DSMA2) is a rare inherited neuromuscular disorder first described in families from the Jerash region of Jordan. It belongs to the group of distal hereditary motor neuropathies (dHMN), which are characterized by progressive weakness and wasting (atrophy) of muscles in the distal parts of the limbs — particularly the hands and feet. Unlike some other motor neuropathies, the Jerash type is distinguished by the presence of upper motor neuron signs, including pyramidal tract involvement with brisk reflexes and extensor plantar responses (Babinski sign), in addition to the lower motor neuron features of distal muscle weakness and atrophy. The disease typically presents in childhood or adolescence with progressive difficulty walking due to weakness and wasting of the lower leg muscles, often leading to foot drop and a steppage gait. Over time, the hands may also become affected, causing difficulty with fine motor tasks. Sensory function is generally preserved, distinguishing this condition from other hereditary neuropathies such as Charcot-Marie-Tooth disease. The combination of lower motor neuron signs (muscle wasting, weakness) with upper motor neuron signs (spasticity, hyperreflexia) can sometimes lead to diagnostic confusion with juvenile amyotrophic lateral sclerosis, though the Jerash type follows a much slower and more benign course. The condition is caused by mutations in the SIGMAR1 gene (also known as the sigma non-opioid intracellular receptor 1 gene) on chromosome 9p13. It follows an autosomal recessive inheritance pattern. There is currently no cure or disease-modifying treatment available. Management is supportive and symptomatic, including physical therapy, occupational therapy, orthotic devices (such as ankle-foot orthoses) to assist with mobility, and regular monitoring by a multidisciplinary team including neurologists and rehabilitation specialists.

Also known as:

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Distal hereditary motor neuropathy, Jerash type.

View clinical trials →

No actively recruiting trials found for Distal hereditary motor neuropathy, Jerash type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Distal hereditary motor neuropathy, Jerash type community →

No specialists are currently listed for Distal hereditary motor neuropathy, Jerash type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Distal hereditary motor neuropathy, Jerash type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Distal hereditary motor neuropathy, Jerash typeForum →

No community posts yet. Be the first to share your experience with Distal hereditary motor neuropathy, Jerash type.

Start the conversation →

Latest news about Distal hereditary motor neuropathy, Jerash type

No recent news articles for Distal hereditary motor neuropathy, Jerash type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Distal hereditary motor neuropathy, Jerash type

What is Distal hereditary motor neuropathy, Jerash type?

Distal hereditary motor neuropathy, Jerash type (also known as dHMN Jerash type or DSMA2) is a rare inherited neuromuscular disorder first described in families from the Jerash region of Jordan. It belongs to the group of distal hereditary motor neuropathies (dHMN), which are characterized by progressive weakness and wasting (atrophy) of muscles in the distal parts of the limbs — particularly the hands and feet. Unlike some other motor neuropathies, the Jerash type is distinguished by the presence of upper motor neuron signs, including pyramidal tract involvement with brisk reflexes and extens

How is Distal hereditary motor neuropathy, Jerash type inherited?

Distal hereditary motor neuropathy, Jerash type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Distal hereditary motor neuropathy, Jerash type typically begin?

Typical onset of Distal hereditary motor neuropathy, Jerash type is childhood. Age of onset can vary across affected individuals.